SFTA1P, LINC00968, GATA6‑AS1, TBX5‑AS1, and FEZF1‑AS1 are crucial long non‑coding RNAs associated with the prognosis of lung squamous cell carcinoma

Xiong,Youwen; Zhang,Xinyi; Lin,Zhuohui; Xiong,Aizhen; Xie,Shanshan; Liang,Jia; Zhang,Weifang

doi:10.3892/ol.2019.10744

SFTA1P, LINC00968, GATA6‑AS1, TBX5‑AS1, and FEZF1‑AS1 are crucial long non‑coding RNAs associated with the prognosis of lung squamous cell carcinoma

Authors:
- Youwen Xiong
- Xinyi Zhang
- Zhuohui Lin
- Aizhen Xiong
- Shanshan Xie
- Jia Liang
- Weifang Zhang
View Affiliations

Affiliations: Department of Pharmacy/Respiratory Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Pharmacy, Jiangmen Central Hospital, Jiangmen, Guangdong 529000, P.R. China
Published online on: August 14, 2019 https://doi.org/10.3892/ol.2019.10744
Pages: 3985-3993
Copyright: © Xiong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer has high incidence and mortality rates, and lung squamous cell carcinoma (LUSC) is a common form of non‑small‑cell lung carcinoma (NSCLC). The aim of our study was to discover long non‑coding RNAs (lncRNAs) associated with LUSC prognosis. RNA‑sequencing data obtained from LUSC samples were extracted from The Cancer Genome Atlas database. Using the limma package, differentially expressed genes (DEGs; including differentially expressed lncRNA genes (DELs), coding genes (DECs), and other genes (DEOs) ) between LUSC and control samples were analyzed. Using Kaplan‑Meier survival analysis, prognosis‑associated lncRNAs were further selected. Following the calculation of Pearson's correlation coefficients between DELs and other DEGs, the DEL‑DEG co‑expression network was visualized using Cytoscape software. Using the clusterProfiler package, potential functions for DECs co‑expressed with DELs were predicted. There were 1,305 DEGs in LUSC samples, including 153 DELs, 1,109 DECs, and 43 DEOs. Based on survival analysis, 22 prognosis‑associated lncRNAs (including surfactant associated 1, pseudogene (SFTA1P), long intergenic non‑protein coding RNA 968 (LINC00968), GATA6 antisense RNA 1, (GATA6‑AS1) TBX5 antisense RNA 1 (TBX5‑AS1) and FEZF1 antisense RNA 1 (FEZF1‑AS1)) in LUSC were selected from these DELs, and the associated abnormal expression levels were also verified in LUSC clinical samples. A DEL‑DEG co‑expression network was constructed, which involved 93 DELs. Co‑expressed DECs were enriched for only 8 prognosis‑associated DELs, including LINC00968, SFTA1P, and TBX5‑AS1. Specifically, mitogen‑activated protein kinase (MAPK) signaling pathway‑associated genes were enriched in DECs co‑expressed with LINC00968, SFTA1P, GATA6‑AS1, TBX5‑AS1 and FEZF1‑AS1, which may be prognosis‑associated lncRNAs in LUSC. In addition, LINC00968 may affect the outcome of patients with LUSC via the MAPK signaling pathway.

View Figures

View References

1	Herbst RS, Heymach JV and Lippman SM: Lung cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
2	Cataldo JK and Brodsky JL: Lung cancer stigma, anxiety, depression and symptom severity. Oncology. 85:33–40. 2013. View Article : Google Scholar : PubMed/NCBI
3	McGuire S: World cancer report 2014. geneva, Switzerland: World health organization, international agency for research on cancer, WHO press, 2015. Adv Nutr. 7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
4	Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc. 83:584–594. 2008. View Article : Google Scholar : PubMed/NCBI
5	Reck M, Heigener DF, Mok T, Soria JC and Rabe KF: Management of non-small-cell lung cancer: Recent developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
6	Perez-Moreno P, Brambilla E, Thomas R and Soria JC: Squamous cell carcinoma of the lung: Molecular subtypes and therapeutic opportunities. Clin Cancer Res. 18:2443–2451. 2012. View Article : Google Scholar : PubMed/NCBI
7	Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell. 136:629–641. 2009. View Article : Google Scholar : PubMed/NCBI
8	Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: Insights into functions. Nat Rev Genets. 10:155–159. 2009. View Article : Google Scholar
9	Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R and Wang MS: LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Int J Clin Exp Pathol. 7:8881–8886. 2014.PubMed/NCBI
10	Zequn N, Xuemei Z, Wei L, Zongjuan M, Yujie Z, Yanli H, Yuping Z, Xia M, Wei W, Wenjing D, et al: The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer. Oncotarget. 7:18219–18228. 2016. View Article : Google Scholar : PubMed/NCBI
11	Zhao QS, Li L, Zhang L, Meng XW, Li LL, Ge XF and Li ZP: Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 20:3031–3034. 2016.PubMed/NCBI
12	Chen J, Hu L, Wang J, Zhang F, Chen J, Xu G, Wang Y and Pan Q: Low expression LncRNA TUBA4B is a poor predictor of prognosis and regulates cell proliferation in non-small cell lung cancer. Pathol Oncol Res. 23:265–270. 2017. View Article : Google Scholar : PubMed/NCBI
13	Cui D, Yu CH, Liu M, Xia QQ, Zhang YF and Jiang WL: Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer. Tumour Biol. 37:4127–4134. 2016. View Article : Google Scholar : PubMed/NCBI
14	Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS and Feng XJ: Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 7:6929–6935. 2014.PubMed/NCBI
15	Schmidt LH, Görlich D, Spieker T, Rohde C, Schuler M, Mohr M, Humberg J, Sauer T, Thoenissen NH, Huge A, et al: Prognostic Impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer. J Thorac Oncol. 9:1294–1304. 2014. View Article : Google Scholar : PubMed/NCBI
16	Servant N, Roméjon J, Gestraud P, La Rosa P, Lucotte G, Lair S, Bernard V, Zeitouni B, Coffin F, Jules-Clément G, et al: Bioinformatics for precision medicine in oncology: Principles and application to the SHIVA clinical trial. Front Genet. 5:1522014. View Article : Google Scholar : PubMed/NCBI
17	Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, et al: TCGAbiolinks: An R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44:e712016. View Article : Google Scholar : PubMed/NCBI
18	Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, et al: GENCODE: The reference human genome annotation for the ENCODE project. Genome Res. 22:1760–1774. 2012. View Article : Google Scholar : PubMed/NCBI
19	Smyth GK: Limma: Linear models for microarray dataSpringer; New York: 2005, View Article : Google Scholar
20	Miettinen OS: Survival analysis: Up from Kaplan-Meier-Greenwood. Eur J Epidemiol. 23:585–592. 2008. View Article : Google Scholar : PubMed/NCBI
21	Cogill SB and Wang L: Co-expression network analysis of human lncRNAs and cancer genes. Cancer Inform. 13 (Suppl 5):S49–S59. 2014.
22	Kohl M, Wiese S and Warscheid B: Cytoscape: Software for visualization and analysis of biological networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
23	Yu G, Wang LG, Han Y and He QY: clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
24	Huang GQ, Ke ZP, Hu HB and Gu B: Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes revealsSFTA1P and CASC2abnormalities in lung squamous cell carcinoma. Cancer Biol Ther. 18:115–122. 2017. View Article : Google Scholar : PubMed/NCBI
25	Li L, Yin JY, He FZ, Huang MS, Zhu T, Gao YF, Chen YX, Zhou DB, Chen X, Sun LQ, et al: Long noncoding RNA SFTA1P promoted apoptosis and increased cisplatin chemosensitivity via regulating the hnRNP-U-GADD45A axis in lung squamous cell carcinoma. Oncotarget. 8:97476–97489. 2017.PubMed/NCBI
26	Park SM, Park SJ, Kim HJ, Kwon OH, Kang TW, Sohn HA, Kim SK, Moo Noh S, Song KS, Jang SJ, et al: A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis. Exp Mol Med. 45:e312013. View Article : Google Scholar : PubMed/NCBI
27	Wang LQ, Wong KY, Li ZH and Chim CS: Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia. Oncotarget. 7:82400–82410. 2016.PubMed/NCBI
28	Zhou B, Francis TA, Yang H, Tseng W, Zhong Q, Frenkel B, Morrisey EE, Ann DK, Minoo P, Crandall ED and Borok Z: GATA-6 mediates transcriptional activation of aquaporin-5 through interactions with Sp1. Am J Physiol Cell Physiol. 295:C1141–C1150. 2008. View Article : Google Scholar : PubMed/NCBI
29	Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, Yang J, DeMayo FJ, Whitsett JA, Parmacek MS and Morrisey EE: A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet. 40:862–870. 2008. View Article : Google Scholar : PubMed/NCBI
30	Herriges MJ, Swarr DT, Morley MP, Rathi KS, Peng T, Stewart KM and Morrisey EE: Long noncoding RNAs are spatially correlated with transcription factors and regulate lung development. Genes Dev. 28:1363–1379. 2014. View Article : Google Scholar : PubMed/NCBI
31	Ma R, Yang Y, Tu Q and Hu K: Overexpression of T-box transcription factor 5 (TBX5) inhibits proliferation and invasion in non-small cell lung carcinoma cells. Oncol Res. 1495–1504. 2017. View Article : Google Scholar : PubMed/NCBI
32	Greulich F, Rudat C and Kispert A: Mechanisms of T-box gene function in the developing heart. Cardiovasc Res. 91:212–222. 2011. View Article : Google Scholar : PubMed/NCBI
33	Ghassemi S, Vejdovszky K, Sahin E, Ratzinger L, Schelch K, Mohr T, Peter-Vörösmarty B, Brankovic J, Lackner A, Leopoldi A, et al: FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo. Oncotarget. 8:87750–87762. 2017. View Article : Google Scholar : PubMed/NCBI
34	Liu Z, Zhao P, Han Y and Lu S: LincRNA FEZF1-AS1 is associated with prognosis in lung adenocarcinoma and promotes cell proliferation, migration and invasion. Onco Res. 27:39–45. 2018. View Article : Google Scholar
35	Jin S, Chen S, Ma Y, Yang B and Liu Y: LincRNA FEZF1-AS1 contributes to the proliferation of LAD cells by silencing p57 expression. Oncotarget. 8:103004–103013. 2017. View Article : Google Scholar : PubMed/NCBI
36	Wang Y, Zhou J, Xu YJ and Hu HB: Long noncoding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway. J Cell Physiol. 233:3397–3406. 2018. View Article : Google Scholar : PubMed/NCBI
37	Zhao R, Chen M, Jiang Z, Zhao F, Xi B, Zhang X, Fu H and Zhou K: Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathways. J Cancer. 6:623–631. 2015. View Article : Google Scholar : PubMed/NCBI
38	Lu Z, Ding L, Hong H, Hoggard J, Lu Q and Chen YH: Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Exp Cell Res. 317:1935–1946. 2011. View Article : Google Scholar : PubMed/NCBI